Calkins Daniel sold $17K of VSTM
Calkins Daniel (Chief Financial Officer) sold 4,089 shares of Verastem, Inc. (VSTM) at an average of $4.18 ($4.13–$4.18) across 2 trades on 2026-06-22 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete datapoint on insider activity but does not include new operational, financial, or regulatory developments.
Market read
Traders may monitor whether this is part of a broader selling cadence, but the single, small 10b5-1 sale is unlikely to drive a major repricing.
What to watch
The sale size is small and explicitly pre-arranged; without additional context (e.g., repeated sales pattern, option exercises), the signal is limited.
Background
This is an SEC Form 4 insider transaction for Verastem, Inc. (VSTM) by CFO Daniel Calkins.
Ticker impact
Verastem CFO Daniel Calkins sold $17.1K of VSTM shares in an open-market transaction under a 10b5-1 plan, disclosed via Form 4.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a routine Form 4 insider sale with a stated 10b5-1 plan and modest dollar value relative to typical market moves.
Market effects
No clear sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even 10b5-1 sales can coincide with internal views on near-term risk; traders may still fade/trim on the headline if liquidity is thin.
Key entities
- issuerVerastem, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderDaniel Calkins
CFO who executed the open-market sale under a 10b5-1 plan.
